Expert Opinion on Drug Safety
Volume 12, 2013 - Issue 5
Open access
725
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor
Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?
Alessandro RivaNovartis Pharmaceuticals Corp.,
One Health Plaza, East Hanover, NJ 07936, USA
Pages 793-795
|
Published online: 12 Aug 2013
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.